Literature DB >> 667962

Stimulation of cell proliferation by histamine H2 receptors in dimethylhdrazine-induced adenocarcinomata.

P J Tutton, D H Barkla.   

Abstract

Cell proliferation in dimethylhydrazine-induced colonic carcinomata was stimulated by histamine and by the histamine H2 receptor agonist dimaprit and inhibited by the histamine H2 receptor antagonists Metiamide and Cimetidine but not by the histamine H1 receptor antagonist Mepyramine. In contrast histamine had no effect on colonic crypt cell proliferation in normal or dimethylhydrazine-treated rats.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 667962     DOI: 10.1016/0309-1651(78)90043-7

Source DB:  PubMed          Journal:  Cell Biol Int Rep        ISSN: 0309-1651


  6 in total

1.  Cytotoxicity of p-chloroamphetamine in dimethylhydrazine-induced carcinomata of rat colon.

Authors:  P J Tutton; D H Barkla
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Influence of biogenic amines on the growth of xenografted human colorectal carcinomas.

Authors:  P J Tutton; G G Steel
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

3.  Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent.

Authors:  Pan Pantziarka; Gauthier Bouche; Lydie Meheus; Vidula Sukhatme; Vikas P Sukhatme
Journal:  Ecancermedicalscience       Date:  2014-11-26

4.  Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists.

Authors:  L T Van der Ven; I M Prinsen; G H Jansen; P J Roholl; R Defferrari; R Slater; W Den Otter
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

5.  Effects of cyclic-nucleotide derivatives on the growth of human colonic carcinoma xenografts and on cell production in the rat colonic crypt epithelium.

Authors:  P J Tutton; D H Barkla
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

6.  Influence of prostaglandin analogues on epithelial cell proliferation and xenograft growth.

Authors:  P J Tutton; D H Barkla
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.